C07D 263/16
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D263/16 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 1,031 US grants and 813 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,031
- Published applications
- 813
- Assignees
- 519
- Inventors
- 3,144
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 17 | 0 |
| 1978 | 11 | 0 |
| 1979 | 8 | 0 |
| 1980 | 7 | 0 |
| 1981 | 10 | 0 |
| 1982 | 10 | 0 |
| 1983 | 10 | 0 |
| 1984 | 17 | 0 |
| 1985 | 14 | 0 |
| 1986 | 5 | 0 |
| 1987 | 10 | 0 |
| 1988 | 10 | 0 |
| 1989 | 20 | 0 |
| 1990 | 19 | 0 |
| 1991 | 24 | 0 |
| 1992 | 29 | 0 |
| 1993 | 25 | 0 |
| 1994 | 11 | 0 |
| 1995 | 24 | 0 |
| 1996 | 24 | 0 |
| 1997 | 30 | 0 |
| 1998 | 30 | 0 |
| 1999 | 22 | 0 |
| 2000 | 29 | 0 |
| 2001 | 35 | 5 |
| 2002 | 33 | 44 |
| 2003 | 41 | 47 |
| 2004 | 29 | 51 |
| 2005 | 23 | 45 |
| 2006 | 26 | 39 |
| 2007 | 29 | 39 |
| 2008 | 28 | 39 |
| 2009 | 10 | 45 |
| 2010 | 26 | 39 |
| 2011 | 20 | 36 |
| 2012 | 22 | 29 |
| 2013 | 18 | 32 |
| 2014 | 32 | 31 |
| 2015 | 22 | 34 |
| 2016 | 32 | 36 |
| 2017 | 36 | 28 |
| 2018 | 23 | 32 |
| 2019 | 21 | 31 |
| 2020 | 25 | 28 |
| 2021 | 15 | 19 |
| 2022 | 12 | 17 |
| 2023 | 14 | 22 |
| 2024 | 15 | 22 |
| 2025 | 15 | 16 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Industrial synthesis of serinol6 Oct 2026US 12,753,146 B2Bracco Imaging S.P.A.
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Low toxicity NMP substitutes and uses thereof25 Aug 2026US 12,715,850 B2Advancion Corporation
- Dihydrooxazole and thiourea derivatives modulating the NLRP3 inflammasome pathway12 May 2026US 12,624,010 B2AC Immune SA
- 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors6 Jan 2026US 12,516,046 B2Merck Sharp & Dohme Corp.
- Substituted oxazolidinones and imidazolinones as herbicides24 Sep 2026US 2026/0285850 A1FMC Corporation
- Method for producing o-substituted serine derivative27 Aug 2026US 2026/0250241 A1Chugai Seiyaku Kabushiki Kaisha
- Process for preparing an n-substituted-2-oxazolidinone23 Jul 2026US 2026/0209192 A1Huntsman Petrochemical Corporation
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
- Compounds and compositions for intracellular delivery of therapeutic agents19 Mar 2026US 2026/0078082 A1ModernaTX, Inc.
Most cited
By later US patents
- Fluorochemical oxazolidinones161US 5,025,052 AMinnesota Mining and Manufacturing Company · 1991
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Heterocyclic compounds114US 4,742,060 ANihon Tokushu Noyaku Seizo K. K. · 1988
- Substituted oxazine and thiazine oxazolidinone antimicrobials113US 5,688,792 APharmacia & Upjohn Company · 1997